Thursday, October 8, 2015

$74.24 million first mortgage financing secured by HFF for 830 Winter Street in Waltham, MA

830 Winter Street, Waltham, MA

 BOSTON, MA – Holliday Fenoglio Fowler, L.P. (HFF) announced it has secured $74.24 million in first mortgage financing for 830 Winter Street, a 182,104-square-foot, Class A lab/biotech building in Waltham, Massachusetts, a western suburb of Boston.

Greg LaBine
HFF worked on behalf of the borrower, a joint venture between King Street Properties and an affiliate of Carlyle Realty Partners VII, LP, in arranging the floating-rate loan with Wells Fargo.

830 Winter Street is situated off Route 95/Route 128 at exit 27 in Waltham about 12 miles west of Boston.  This location places the asset between Route 2 to the north and Interstate 90/the Massachusetts Turnpike to the south and in close proximity to the new 1265 Main Street mixed-use development. 

Completed in 2001 as the flagship headquarters for Praecis Pharmaceuticals, the property remains fully leased today to ImmunoGen, GlaxoSmithKline and Histogenics Corporation.

The HFF debt placement team representing the borrower was led by managing director Greg LaBine.

“This is one of the premier laboratory facilities in the Boston suburbs,” said LaBine.  “As is the case with many acquisitions in the current market environment, the financing had to be obtained quickly to hit the tight closing time frame.  HFF, along with a tremendous effort by the Wells Fargo team, was able to close the deal within 54 days of our initial engagement.”

  For a complete copy of the company’s news release, please contact:

Kristen M. Murphy
Associate Director
HFF | One Post Office Square, Suite 3500 | Boston, MA 02109
Main: 617-338-0990 | Direct: 617-848-1572 | Cell: 617-543-4873 |

No comments: